"Untitled"Neuroblastoma-specific Clinical Trials
For a Newly Diagnosed Patient
There are currently no listings. Please check back.
For a Patient with Recurrent or Relapsed Disease
NANT 2001-02: Phase I Study of CEP-701 (New Agent)
NANT 2003-01: Phase I Study of Oral Irinotecan, Temozolomide, and Cefixime (New Agent)
NANT 2004-01 Phase I Trial of Zometa with Cyclophosphamide (New Agent)
Page modified on October 2, 2021